Common Contracts
2 similar Underwriting Agreement contracts by Onyx Pharmaceuticals Inc, Teleflex Inc
Teleflex Incorporated $350,000,000 3.875% Convertible Senior Subordinated Notes Due 2017 Underwriting AgreementUnderwriting Agreement • August 9th, 2010 • Teleflex Inc • Surgical & medical instruments & apparatus • New York
Teleflex Incorporated, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this Underwriting Agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of $350,000,000 principal amount (the “Firm Securities”) of its Convertible Senior Subordinated Notes due 2017 (the “Notes”), which are convertible into shares of the Company’s common stock, $1 par value (“Stock”), and, at the election of the Underwriters, up to an aggregate of $50,000,000 in additional aggregate principal amount of Notes (the “Optional Securities”) (the Firm Securities and the Optional Securities which the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”). The Securities will be issued pursuant to an indenture, dated as of August 2, 2010 (the “Base Indenture”) by and between the Company and Wells Fargo Bank, N.A., as trustee (the “Trustee”), as supp
Onyx Pharmaceuticals, Inc. 4.00% Convertible Senior Notes Due 2016 Underwriting AgreementUnderwriting Agreement • August 7th, 2009 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
The undersigned understands that you, as representative (the “Representative”), propose to enter into (i) an Underwriting Agreement (the “Common Stock Underwriting Agreement”) on behalf of the several underwriters named in Schedule I to such agreement (the “Common Stock Underwriters”), with Onyx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), providing for the offer and sale of the common stock of the Company, $0.001 par value per share (the “Stock”) and (ii) an Underwriting Agreement (the “Convertible Notes Underwriting Agreement”) on behalf of the several underwriters named in Schedule I to such agreement (the “Convertible Notes Underwriters”), with the Company, providing for the offer and sale of the Company’s Convertible Senior Notes due 2016 (the “Notes” and, together with the Stock, the “Securities”). The Notes will be convertible into shares of Stock.
